Pricing Log in Create free account

Bright Minds Biosciences Inc. (DRUG) vs InflaRx N.V. (IFRX)

Bright Minds Biosciences Inc. and InflaRx N.V. are both Biotechnology companies. Bright Minds Biosciences Inc. is the larger, with a market value of $226.9M against $192.3M — 1.2× the size. Across the 10 metrics below, Bright Minds Biosciences Inc. leads on 8 and InflaRx N.V. on 2.

Valuation

Metric DRUG IFRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6,308.89 9.40
P/B 1.02 1.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1,845.43 9.02
Earnings yield (9.04%) (29.70%) (32.88%)
Free cash flow yield (7.85%) (10.67%) (23.13%)

Profitability

Metric DRUG IFRX Biotechnology median
Gross margin 0.00% (26,762.42%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (13.64%) (30.98%) (51.96%)
Return on assets (13.52%) (25.90%) (46.06%)
Return on invested capital 0.00% (87.31%) 0.00%

Growth

Metric DRUG IFRX Biotechnology median
Revenue growth (TTM) — (83.39%) 6.76%
EPS growth (last fiscal year) (164.58%) 9.41% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRUG IFRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 121.98 7.26 4.97
Net debt to EBITDA 5.98 0.97 1.01

Dividend

Metric DRUG IFRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DRUG IFRX Biotechnology median
Market cap 226.87m 192.32m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack